2m 2m 2m 2m 2m 2m 2m
Northwest Bio (NWBO)
OTC
$0.17+$0.004 (+2.21%)
Price as of Sep 11, 2026- $308.1MMarket Cap
- -34.99%1-Year Change
- BiotechnologyIndustry
Northwest Bio (NWBO)
$0.17+$0.004 (+2.21%)
NWBO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.17 | ||
Change | +$0.004 (+2.21%) | ||
Open | $0.17 | ||
High | $0.17 | ||
Low | $0.16 | ||
Previous Close | $0.17 | ||
Volume | 1,207,103 | ||
30-Day Average Volume | 3,413,908 | ||
1-Week Change | -0.44% | ||
1-Month Change | -11.11% | ||
1-Year Change | -34.99% | ||
3-Year Change | -73.65% | ||
5-Year Change | -70.29% | ||
Fundamentals | |||
Shares Outstanding | 1.5B | ||
Total Assets | $30.6M | ||
Market Cap | $308.1M | ||
Enterprise Value | $324.3M | ||
Period: QTR TTM FY | |||
Revenue | $200,000.00 | ||
Net Income | -$26.8M | ||
Free Cash Flow | -$14.1M | ||
EBIT | -$26.8M | ||
EBITDA | -$26.4M | ||
Net Working Capital | -$80.7M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 1,622 | ||
P/B | -3 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 16 | ||
Last Split Date | 09/26/2012 | ||